ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $515,000 | -65.9% | 12,744 | -51.5% | 0.00% | -77.8% |
| Q2 2015 | $1,512,000 | -84.6% | 26,259 | -82.9% | 0.01% | -87.8% |
| Q1 2015 | $9,793,000 | -34.8% | 153,800 | -36.8% | 0.07% | -35.1% |
| Q4 2014 | $15,027,000 | +2081.0% | 243,400 | +1117.0% | 0.11% | +1528.6% |
| Q2 2014 | $689,000 | -14.0% | 20,000 | -0.5% | 0.01% | +16.7% |
| Q4 2013 | $801,000 | -47.2% | 20,100 | -50.2% | 0.01% | +100.0% |
| Q3 2013 | $1,518,000 | -65.0% | 40,400 | -75.0% | 0.00% | -81.2% |
| Q2 2013 | $4,342,000 | – | 161,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |